News

Key Takeaways The U.S. Food and Drug Administration has given its nod to a new treatment for chronic hand eczemaAnzupgo is ...
The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.
Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...
The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.